Evaluation of immune effects of fowlpox vaccine strains and field isolates.
The immune effects of fowlpox virus (FPV) field isolates and vaccine strains were evaluated in chickens infected at the age of 1 day and 6 weeks. The field isolates and the obsolete vaccine strain (FPV S) contained integrated reticuloendotheliosis virus (REV) provirus, while the current vaccine strain (FPVST) carries only REV LTR sequences. An indirect antibody ELISA was used to measure the FPV-specific antibody response. The non-specific humoral response was evaluated by injection of two T-cell-dependent antigens, sheep red blood cells (SRBC) and bovine serum albumin (BSA). There was no significant difference in the antibody response to FPV between chickens infected with FPV various isolates and strains at either age. In contrast, antibody responses to both SRBC and BSA were significantly lower in 1-day-old chickens inoculated with field isolates and FPV S at 2-3 weeks post-inoculation. Furthermore, cell-mediated immune (CMI) responses measured by in vitro lymphocyte proliferation assay and in vivo using a PHA-P skin test were significantly depressed in chickens inoculated with field isolates and FPV S at the same periods. In addition, thymus and bursal weights were lower in infected chickens. These immunosuppressive effects were not observed in chickens inoculated with the current vaccine strain, FPVST, at any time. The results of this study suggest that virulent field isolates and FPV S have immunosuppressive effects when inoculated into young chickens, which appeared in the first 3 weeks post infection. REV integrated in the FPV field isolates and FPV S may have played a central role in the development of immunosuppression.
Wang
Jianning
J
Investigation & Diagnostic Centre-Wallaceville, Biosecurity New Zealand, Ministry of Agriculture & Forestry, Ward Street, Upper Hutt 6007, New Zealand. jianning.wang@maf.govt.nz
Meers
Joanne
J
Spradbrow
Peter B
PB
Robinson
Wayne F
WF
D000818:Animals; D000914:Antibodies, Viral / Q000302:isolation & purification; D002060:Bursa of Fabricius / Q000473:pathology; D002645:Chickens / Q000276:immunology*; D005586:Fowlpox / Q000276:immunology* / Q000517:prevention & control; D005587:Fowlpox virus / Q000145:classification* / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D009929:Organ Size; D011201:Poultry Diseases / Q000276:immunology / Q000517:prevention & control; D012367:RNA, Viral; D012867:Skin / Q000276:immunology; D013869:Thiolester Hydrolases; D013950:Thymus Gland / Q000473:pathology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D012367:RNA, Viral; D014765:Viral Vaccines; C402226:LYPLA1 protein, human; D013869:Thiolester Hydrolases